Abstract:Ethnopharmacological relevanceLiver fibrosis is a chronic liver disease that can lead to cirrhosis, liver failure, and hepatocellular carcinoma, and it is associated with long-term adverse outcomes and mortality. As a primary resource for complementary and alternative medicine, traditional Chinese medicine (TCM) has accumulated a large number of effective formulas for the treatment of liver fibrosis in clinical practice. However, studies on how to systematically optimize TCM formulas are still lacking.Aim of the reviewTo provide a methodological reference for the systematic optimization of TCM formulae against liver fibrosis and explored the underlying molecular mechanisms; To provide an efficient method for searching for lead compounds from natural sources and developing from herbal medicines; To enable clinicians and patients to make more reasonable choices and promote the effective treatment toward those patients with liver fibrosis.Materials and methodsTCM formulas related to treating liver fibrosis were collected from the Web of Science, PubMed, the China National Knowledge Infrastructure (CNKI), Wan Fang, and the Chinese Scientific Journals Database (VIP). Furthermore, the TCM compatibility patterns were mined using association analysis. The core TCM combinations were found by designing an optimized formulas algorithm. Finally, the hub target proteins, potential molecular mechanisms, and active compounds were explored through integrative pharmacology and docking-based inverse virtual screening (IVS) approaches.ResultsWe found that the herbs for reinforcing deficiency, activating blood, removing blood stasis, and clearing heat were the basis of TCM formulae patterns. Furthermore, the combination of Salviae Miltiorrhizae (Salvia miltiorrhiza Bunge; Chinese salvia/Danshen), Astragali Radix (Astragalus membranaceus (Fisch.) Bunge; Astragalus/Huangqi), and Radix Bupleuri (Bupleurum chinense DC.; Bupleurum/Chaihu) was identified as core groups. A total of six targets (TNF, STAT3, EGFR, IL2, ICAM1, PTGS2) play a pivotal role in TCM-mediated liver fibrosis inhibition. (−)-Cryptotanshinone, Tanshinaldehyde, Ononin, Thymol, Daidzein, and Formononetin were identified as active compounds in TCM. And mechanistically, TCM could affect the development of liver fibrosis by regulating inflammation, immunity, angiogenesis, antioxidants, and involvement in TNF, MicroRNAs, Jak-STAT, NF-kappa B, and C-type lectin receptors (CLRs) signaling pathways. Molecular docking results showed that key components had good potential to bind to the target genes.ConclusionIn summary, this study provides a methodological reference for the systematic optimization of TCM formulae and exploration of underlying molecular mechanisms.

[Optimization of a compound prescription for treating liver fibrosis]

TAK-242 Ameliorates Hepatic Fibrosis by Regulating the Liver-Gut Axis

Liver Fibrosis Therapy Based on Biomimetic Nanoparticles Which Deplete Activated Hepatic Stellate Cells.

Optimization of Tetrandrine Treatment in Rat Hepatic Fibrosis Model

An optimized herbal combination for the treatment of liver fibrosis: Hub genes, bioactive ingredients, and molecular mechanisms

Rational design, synthesis and activities of phenanthrene derivatives against hepatic fibrosis

Experimental Study of Amydae Carapax Decoction on Prevention & Treatment of Liver Fibrosis in Rats Induced by Two Different Causes

Active Components Formulation Developed from Fuzheng Huayu Recipe for Anti-Liver Fibrosis

Liver-targeted delivery of asiatic acid nanostructured lipid carrier for the treatment of liver fibrosis

[Therapeutic Effects of Compound Glycyrrhizin Liposome on Fibrosis of the Rats with Nonalcoholic Steatohepatitis].

An Experimental Contrast Study of Tetrandrine on Anti-hepatofibrosis

Design, synthesis and anti-NASH effect evaluation of novel GFT505 derivatives in vitro and in vivo

Experimental Research into the Effect of Simple Recipe and Their Interaction of Dan-shen Root,Milk Veteh and Flavescent Sophora on the Rat Model of Liver Fibrosis

The Therapeutic Effects of Tectorigenin on Chemically Induced Liver Fibrosis in Rats and an Associated Metabonomic Investigation

Optimization of clofibrate with O-desmethyl anetholtrithione lead to a novel hypolipidemia compound with hepatoprotective effect

Discovery of 1,8-naphthalidine derivatives as potent anti-hepatic fibrosis agents via repressing PI3K/AKT/Smad and JAK2/STAT3 pathways

Advances in Anti Hepatic Fibrotic Therapy with Traditional Chinese Medicine Herbal Formula.

Structure-based design and synthesis of anti-fibrotic compounds derived from para-positioned 3,4,5-trisubstituted benzene

Design of a highly potent GLP-1R and GCGR dual-agonist for recovering hepatic fibrosis

Total flavonoids extracted from Penthorum chinense Pursh mitigates CCl4-induced hepatic fibrosis in rats via inactivation of TLR4-MyD88-mediated NF-κB pathways and regulation of liver metabolism

Research on the anti-hepatic fibrosis effects and active components of the medicinal plant Tithonia diversifolia